Logo image of BILI

BILIBILI INC-SPONSORED ADR (BILI) Stock Fundamental Analysis

USA - NASDAQ:BILI - US0900401060 - ADR

29.98 USD
+0.52 (+1.77%)
Last: 10/27/2025, 8:05:11 PM
31 USD
+1.02 (+3.4%)
Pre-Market: 10/28/2025, 9:19:49 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BILI. BILI was compared to 70 industry peers in the Interactive Media & Services industry. Both the profitability and financial health of BILI have multiple concerns. BILI shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BILI was profitable.
In the past 5 years BILI always reported negative net income.
In multiple years BILI reported negative operating cash flow during the last 5 years.
BILI Yearly Net Income VS EBIT VS OCF VS FCFBILI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B -6B

1.2 Ratios

With a Return On Assets value of 0.57%, BILI perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
BILI has a Return On Equity (1.56%) which is in line with its industry peers.
BILI's Return On Invested Capital of 1.05% is in line compared to the rest of the industry. BILI outperforms 54.29% of its industry peers.
Industry RankSector Rank
ROA 0.57%
ROE 1.56%
ROIC 1.05%
ROA(3y)-12.19%
ROA(5y)-12.45%
ROE(3y)-30.75%
ROE(5y)-32.63%
ROIC(3y)N/A
ROIC(5y)N/A
BILI Yearly ROA, ROE, ROICBILI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

The Profit Margin of BILI (0.75%) is comparable to the rest of the industry.
BILI has a Operating Margin of 1.11%. This is comparable to the rest of the industry: BILI outperforms 54.29% of its industry peers.
BILI has a worse Gross Margin (35.91%) than 78.57% of its industry peers.
BILI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.11%
PM (TTM) 0.75%
GM 35.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.17%
GM growth 5Y13.25%
BILI Yearly Profit, Operating, Gross MarginsBILI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BILI is destroying value.
BILI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BILI has been increased compared to 5 years ago.
Compared to 1 year ago, BILI has an improved debt to assets ratio.
BILI Yearly Shares OutstandingBILI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
BILI Yearly Total Debt VS Total AssetsBILI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

BILI has an Altman-Z score of 2.24. This is not the best score and indicates that BILI is in the grey zone with still only limited risk for bankruptcy at the moment.
BILI has a Altman-Z score of 2.24. This is in the better half of the industry: BILI outperforms 62.86% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that BILI is somewhat dependend on debt financing.
The Debt to Equity ratio of BILI (0.69) is worse than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z 2.24
ROIC/WACC0.13
WACC8.09%
BILI Yearly LT Debt VS Equity VS FCFBILI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B 20B

2.3 Liquidity

BILI has a Current Ratio of 1.60. This is a normal value and indicates that BILI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.60, BILI is in line with its industry, outperforming 42.86% of the companies in the same industry.
BILI has a Quick Ratio of 1.60. This is a normal value and indicates that BILI is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.60, BILI perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
BILI Yearly Current Assets VS Current LiabilitesBILI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 173.11% over the past year.
The Revenue has grown by 22.70% in the past year. This is a very strong growth!
Measured over the past years, BILI shows a very strong growth in Revenue. The Revenue has been growing by 31.68% on average per year.
EPS 1Y (TTM)173.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%298.46%
Revenue 1Y (TTM)22.7%
Revenue growth 3Y11.45%
Revenue growth 5Y31.68%
Sales Q2Q%19.76%

3.2 Future

The Earnings Per Share is expected to grow by 206.29% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.19% on average over the next years. This is quite good.
EPS Next Y8061.65%
EPS Next 2Y970.95%
EPS Next 3Y433.9%
EPS Next 5Y206.29%
Revenue Next Year12.68%
Revenue Next 2Y10.78%
Revenue Next 3Y10.08%
Revenue Next 5Y11.19%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BILI Yearly Revenue VS EstimatesBILI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B 50B
BILI Yearly EPS VS EstimatesBILI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 -10 20 30

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 56.57, the valuation of BILI can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of BILI is on the same level as its industry peers.
BILI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.08.
A Price/Forward Earnings ratio of 27.01 indicates a quite expensive valuation of BILI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BILI is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.09, BILI is valued at the same level.
Industry RankSector Rank
PE 56.57
Fwd PE 27.01
BILI Price Earnings VS Forward Price EarningsBILI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

BILI's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.04
BILI Per share dataBILI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BILI's earnings are expected to grow with 433.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y970.95%
EPS Next 3Y433.9%

0

5. Dividend

5.1 Amount

No dividends for BILI!.
Industry RankSector Rank
Dividend Yield N/A

BILIBILI INC-SPONSORED ADR

NASDAQ:BILI (10/27/2025, 8:05:11 PM)

Premarket: 31 +1.02 (+3.4%)

29.98

+0.52 (+1.77%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)08-21 2025-08-21/bmo
Earnings (Next)11-13 2025-11-13/bmo
Inst Owners11.53%
Inst Owner Change0.03%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap12.40B
Revenue(TTM)29.38B
Net Income(TTM)220.34M
Analysts82.78
Price Target28.33 (-5.5%)
Short Float %4.01%
Short Ratio3.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.52%
Min EPS beat(2)5.79%
Max EPS beat(2)41.24%
EPS beat(4)3
Avg EPS beat(4)12.26%
Min EPS beat(4)-7.94%
Max EPS beat(4)41.24%
EPS beat(8)6
Avg EPS beat(8)10.27%
EPS beat(12)10
Avg EPS beat(12)10.09%
EPS beat(16)13
Avg EPS beat(16)7.45%
Revenue beat(2)0
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-1.82%
Max Revenue beat(2)-0.72%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-1.82%
Max Revenue beat(4)0.42%
Revenue beat(8)1
Avg Revenue beat(8)-1.16%
Revenue beat(12)1
Avg Revenue beat(12)-1.45%
Revenue beat(16)1
Avg Revenue beat(16)-1.51%
PT rev (1m)1.7%
PT rev (3m)9.28%
EPS NQ rev (1m)0.51%
EPS NQ rev (3m)6.9%
EPS NY rev (1m)0.72%
EPS NY rev (3m)6.5%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.84%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.96%
Valuation
Industry RankSector Rank
PE 56.57
Fwd PE 27.01
P/S 3
P/FCF N/A
P/OCF N/A
P/B 6.22
P/tB 10.47
EV/EBITDA 22.04
EPS(TTM)0.53
EY1.77%
EPS(NY)1.11
Fwd EY3.7%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.99
BVpS4.82
TBVpS2.86
PEG (NY)0.01
PEG (5Y)N/A
Graham Number7.58
Profitability
Industry RankSector Rank
ROA 0.57%
ROE 1.56%
ROCE 1.43%
ROIC 1.05%
ROICexc 11.6%
ROICexgc N/A
OM 1.11%
PM (TTM) 0.75%
GM 35.91%
FCFM N/A
ROA(3y)-12.19%
ROA(5y)-12.45%
ROE(3y)-30.75%
ROE(5y)-32.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.17%
GM growth 5Y13.25%
F-ScoreN/A
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA 3.47
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 2.24
F-ScoreN/A
WACC8.09%
ROIC/WACC0.13
Cap/Depr(3y)66.04%
Cap/Depr(5y)95.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)12.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)173.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%298.46%
EPS Next Y8061.65%
EPS Next 2Y970.95%
EPS Next 3Y433.9%
EPS Next 5Y206.29%
Revenue 1Y (TTM)22.7%
Revenue growth 3Y11.45%
Revenue growth 5Y31.68%
Sales Q2Q%19.76%
Revenue Next Year12.68%
Revenue Next 2Y10.78%
Revenue Next 3Y10.08%
Revenue Next 5Y11.19%
EBIT growth 1Y108.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year394.37%
EBIT Next 3Y86.04%
EBIT Next 5Y51.06%
FCF growth 1Y500.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2155.95%
OCF growth 3YN/A
OCF growth 5Y98.62%

BILIBILI INC-SPONSORED ADR / BILI FAQ

Can you provide the ChartMill fundamental rating for BILIBILI INC-SPONSORED ADR?

ChartMill assigns a fundamental rating of 3 / 10 to BILI.


What is the valuation status of BILIBILI INC-SPONSORED ADR (BILI) stock?

ChartMill assigns a valuation rating of 3 / 10 to BILIBILI INC-SPONSORED ADR (BILI). This can be considered as Overvalued.


How profitable is BILIBILI INC-SPONSORED ADR (BILI) stock?

BILIBILI INC-SPONSORED ADR (BILI) has a profitability rating of 2 / 10.


What are the PE and PB ratios of BILIBILI INC-SPONSORED ADR (BILI) stock?

The Price/Earnings (PE) ratio for BILIBILI INC-SPONSORED ADR (BILI) is 56.57 and the Price/Book (PB) ratio is 6.22.